Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax - 06 July 2021 23:40

PROVIDENCE, R.I., July 6, 2021 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr. Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Logo ...

  South-Korean biotech Y-Biologics and French mid-pharma Pierre ... - 06 July 2021 18:00

DAEJEON, South Korea and CASTRES, France, July 6, 2021 29 /PRNewswire-AsiaNet/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered into a license agreement granting worldwide exclusive rights to Pierre Fabre to develop and commercialize a family of human antibodies gener...

  Inbiose applies for FDA GRAS approval of four new Human Milk O... - 06 July 2021 17:00

GHENT, Belgium, July 6, 2021 /PRNewswire-AsiaNet/ -- Inbiose, a leading biotech company active in the development of Human Milk Oligosaccharides (HMOs), is pleased to announce that it has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administratio...

  Bora Group announce the rebranding of Yuta Health to Bora Health - 06 July 2021 15:33

TAIPEI, July 6, 2021 /PRNewswire-AsiaNet/ -- Leading Taiwan-based contract development and manufacturing organization (CDMO) Bora Group today announced a name change for its subsidiary, currently Yuta Health, to Bora Health Inc. as part of an overall plan to integrate its distribution operat...

  SINOMED announces a clinical collaboration with the National U... - 05 July 2021 21:42

TIANJIN, China, July 5, 2021 /PRNewswire-AsiaNet/ -- SINOMED, a leading international medical device company, today announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting. The trial will empl...

  Octapharma's Ongoing Dedication to Improving the Lives of Peop... - 05 July 2021 21:30

LACHEN, Switzerland, July 5, 2021 /PRNewswire-AsiaNet/ -- Octapharma announced today that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq(R), wilate(R), octanate(R) and octanine(R)F, will be presented at the upcoming International Society on Thrombosis and H...

  Insightec Announces Registration Approval Of Exablate Neuro By... - 05 July 2021 10:00

HAIFA, Israel and MIAMI, July 5, 2021 /PRNewswire-AsiaNet/ -- Positive momentum continues to bring Focused Ultrasound to global patients living with Essential Tremor and Tremor-dominant Parkinson's Disease Insightec(R) [ http://www.insightec.com/ ], a global healthcare company focused on creating the next...

  Love Your Body. Change Your World. USANA Proudly Launches New ... - 05 July 2021 09:13

SYDNEY, July 5, 2021 /PRNewswire-AsiaNet/ -- - Introducing USANA's new Active Nutrition line—six high-quality products for whole-body health USANA Health Sciences, a global leader in nutrition, is proud to announce its brand-new Active Nutrition product line. Recently launched to the publ...

  Tianjin Haihe Media Group presents an extraordinary story of a... - 03 July 2021 20:32

TIANJIN, China, July 3, 2021, /PRNewswire-AsiaNet/-- Zhang Boli, director of the Tianjin University of Traditional Chinese Medicine in China, was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight aga...

  Tianjin Haihe Media Group presents the story of Zhang Boli in ... - 02 July 2021 22:33

TIANJIN, China, July 2, 2021 /PRNewswire-AsiaNet/ -- In September 2020, Zhang Boli was awarded with the national honorary title "the People's Hero" by the Chinese central government for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to com...